etically modified mouse strain with human-like atherosclerosis, a mini-
stent, and experimental coatings on the stent. Joint venture partners other
than Nanocopoeia and Western include Stentome, LLC, an interventional
cardiology company based in Palo Alto, CA, Oxford, UK, and Galway, Ireland,
and The Integra Group, a medical research organization based in Brooklyn
Park, MN, that provides a full range of preclinical and clinical
development services. NanoInterventions was a featured company in the
Positively Minnesota pavilion in the BIO International exhibition hall,
from June 17-20, 2008.
With annual research expenditures of more than $223 million and an
international reputation for success, The University of Western Ontario
ranks as one of the top ten research-intensive universities in Canada.
Offering Canada's best student experience among its peers, Western and its
affiliated research institutes provide a culture that encourages
entrepreneurial research and innovation.
WORLDiscoveries(TM) is a joint venture between Lawson Health Research
Institute and The University of Western Ontario, including Robarts Research
Institute, that capitalizes on the institutions' combined research
strengths related to medical and health-related sciences, energy and the
environment and new materials. The London region is recognized as a
national leader in these key areas, and the city has identified them as
opportunities for further growth.
Rob Herold, Associate Director of Western's Industrial Liaison Office,
commented, "The innovative structure of our licensing partnership with
Nanocopoeia lets us participate in the evolving healthcare applications of
this polymer platform. WORLDiscoveries(TM) was structured to enable us work
with highly entrepreneurial companies like Nanocopoeia and share in their
upside potential, in addition to the standard licensing process that we
have traditionally used. We have great confidence both in the technology
and in our new part
'/>"/>
SOURCE Nanocopoeia Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 Related biology technology :1.
VTT Technical Research Centre of Finland Licenses MetaCore from GeneGo for Cancer Research and Diagnostics2.
Access Licenses ProLindac(TM) to Jiangsu Aosaikang Pharmaceutical Co., LTD., a Leading Oncology Pharmaceutical Company for Manufacturing, Development and Commercialization in the Greater China Region3.
Cepheid Market Reach Extended with Licenses in Canada and Registrations in Mexico4.
USGI Medical Licenses Incisionless Surgery Technology to Intuitive Surgical5.
Dalton Pharma Services Licenses Thermo Fisher Scientific Technology to Produce Polynucleotides for Drug Development6.
Japan Patent Office Licenses GeneCards(R) from Xennex, Inc.7.
Intradigm Licenses Key Next Generation RNA Interference (RNAi) Intellectual Property From University of Massachusetts Medical School8.
PerOs obtains USDA Establishment and Product Licenses for its oral vaccine formulations9.
Lentigen Licenses Fundamental Lentiviral Vector Technology Patent From the University of Cambridge10.
U.S. FDA Licenses DAPTACEL(R) Vaccine for the Fifth Consecutive Dose in the Pediatric DTaP Immunization Series11.
Egenix Licenses Harvard Anti-Cancer Platform